Skip to main content

SMD

1
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
1
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Cell Technologies
Cell TechnologiesAB - Calgary
1 program
1
ACADESINE 140mg/kg/dPhase 1/2
AdvanCell
AdvanCellAustralia - Pullenvale
1 program
ACADESINE 140mg/kg/dPHASE_1_21 trial
Active Trials
NCT01813838Terminated5Est. Jun 2015

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AdvanCellACADESINE 140mg/kg/d

Clinical Trials (1)

Total enrollment: 5 patients across 1 trials

NCT01813838AdvanCellACADESINE 140mg/kg/d

GFM-Acadesine: A Phase I-II Trial of Acadesine

Start: Jun 2013Est. completion: Jun 20155 patients
Phase 1/2Terminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.